Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. S. branded prescription market leader for adults with irritable bowel syndrome with constipation or chronic idiopathic constipation.

Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure, as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. The Director, Head of Drug Product Analytical Operations leads analytical development and lifecycle support for drug products, peptide-based products, medical devices, combination products, and related packaging within CMC activities.

The role provides strategic and technical leadership across Technical Operations, Quality, Regulatory CMC, and external partners to support development, technical transfers , process validation, regulatory submissions, clinical bulk supply readiness, commercial preparedness, and lifecycle management. This position oversees outsourced analytical programs, drives risk-based decisions, ensures compliance with global regulatory standards, and leads teams to foster collaboration and operational excellence. Essential Functions Leadership and Team Development: - Lead and develop the Analytical Drug Product team, fostering excellence, collaboration, innovation, and continuous improvement.

Outsourced Analytical Management: - Oversee outsourced analytical development at CROs/CDMOs, ensuring phase-appropriate strategy, quality, governance, and alignment with project priorities. - Build external partnerships and review key technical documents to support compliant execution, issue escalation, and lifecycle changes. Drug Product, Medical Device, and Combination Product Development within CMC Activities: - Lead analytical strategy for drug products, devices, and combination products, including methods, characterization, stability, extractables and leachables , and peptide-specific support.

- Oversee impurity, degradation, release, stability, comparability, and compatibility assessments critical to development and lifecycle management. - Partner with CMC and product teams to support development, regulatory submissions, clinical bulk supply including release and stability , and lifecycle plans. - Ensure stability programs meet global expectations and support shelf life, product quality, and compliance.

Regulatory Support: - Prepare and review analytical content for global regulatory submissions covering drug products, packaging, and combination products. - Serve as an analytical lead for health authority interactions, ensuring compliant methods, data, specifications, and lifecycle support. - Lead responses to agency questions, inspections, and audits with sound analytical justification.

Primary and Secondary Packaging: - Oversee analytical evaluation of primary and secondary packaging, including integrity, extractables and leachables , and compatibility testing. - Ensure packaging studies are integrated into stability and lifecycle programs Cross-Functional Collaboration: - Partner across Technical Operations , Clinical Supply, Manufacturing, Supply Chain, Quality, Regulatory CMC, and program teams to integrate analytical support. - Provide analytical leadership in governance, technical transfer, issue resolution, and risk-based decision-making across external sites and product teams.

Budget and Resource Management: - Manage Analytical budgets for Drug product, combination product and resources effectively, including oversight of external spending and cost optimization.